In first-line metastatic colorectal cancer (mCRC), baseline prognostic factors allowing death risk and treatment...
Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : International Journal of Cancer
Background: The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better...
Posté par : Dr. Dewi VERNEREY, , Pr. Franck BONNETAIN
Nom de la revue : British Journal of Cancer
Our aim was to review the studies which assessed potential surrogate endpoints for overall survival (OS) in breast...
Posté par : Pr. Franck BONNETAIN,
Nom de la revue : Breast
In the Intergroupe Francophone de Cancérologie Thoracique 0501 trial the carboplatinpaclitaxel chemotherapy increased...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : European Respiratory Journal
Background: Even though the perioperative chemotherapy improves the overall survival (OS) compared to surgery alone in...
Posté par : Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Nom de la revue : European Journal of Surgical Oncology
PurposeWe previously showed that a sequential chemotherapy with dose-dense oxaliplatin (FOLFOX7)and irinotecan (FOLFIRI;...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : PLOS ONE
AbstractGlioblastoma is the most common malignant brain tumor in adults. Baselinehealth-relatedquality of life (HRQoL)...
Posté par : , Dr. Dewi VERNEREY, , Pr. Franck BONNETAIN
Nom de la revue : Cancer Medicine
OBJECTIVES: The objective of this study was to explore the association between health-related quality of life (HRQoL)...
Posté par : , Pr. Franck BONNETAIN
Nom de la revue : BMJ Open
09
Mai, 2016
OBJECTIVES: We conducted a prospective study approved by the local ethics committee to determine the impact of a...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : Annales pharmaceutiques françaises
IMPORTANCE In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : JAMA
Health-related quality of life (HRQOL) in cancer research is critical to more comprehensively evaluate patients’...
Posté par : Pr. Franck BONNETAIN, ,
Nom de la revue : Journal of Clinical Oncology
AbstractBackground: Health-related quality of life (HRQoL) is recognized as a component endpoint for cancer...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : BMC Cancer
Background: Deficient mismatch repair (dMMR) colon cancer (CC) is reportedly resistant to 5-fluorouracil (5FU) adjuvant...
Posté par : , Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : JNCI Journal of the National Cancer Institure
AbstractBACKGROUND:We investigated whether the health-related quality of life (HRQoL) score is a prognostic factor for...
Posté par : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY
Nom de la revue : EJC
Purpose Eastern Cooperative Oncology Group Performance Status (ECOG-PS) is currently an important parameter in the...
Posté par : Pr. Franck BONNETAIN
Nom de la revue : Quality of Life Research
AbstractPURPOSE:The MOSAIC (Multicenter International Study of Oxaliplatin/Fluorouracil/Leucovorin in the Adjuvant...
Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : JCO
AbstractBACKGROUND:The combination of an anti-VEGF or an anti-EGFR-targeted monoclonal antibody with chemotherapy has...
Posté par : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Nom de la revue : Lancet Oncol
ABSTRACT Rationale:The role of circulating antibodies in addition to traditional cardiovascular risk factors in...
Posté par : Dr. Dewi VERNEREY
Nom de la revue : Test
AbstractOBJECTIVES:To assess the long term outcomes of transplantation using expanded criteria donors (ECD; donors aged...
Posté par : Dr. Dewi VERNEREY
Nom de la revue : BMJ
AbstractAIM:Microarray studies identified a subgroup of molecular apocrine tumors (estrogen receptor [ER]...
Posté par : Dr. Dewi VERNEREY
Nom de la revue : Future Oncol